9am.health is a direct-to-consumer virtual diabetes clinic that provides care to patients living with pre-diabetes and type 2 diabetes. The company provides medications, labs, a personal treatment plan and access to a care team for the price of a typical co-pay.
Working at the intersection of community care and healthcare, Feebris’ AI-powered platform empowers a direct care workforce to perform clinical grade examinations on the most vulnerable populations in their own home. Feebris works on- or offline, ideal for use in rural and underserved communities, thus promoting health equity and a uniformly high standard of early disease detection. Its use by the NHS in UK elderly care facilities throughout the pandemic has evidenced a substantial positive ROI, including measurable reduction in avoidable hospitalizations and accelerated access to treatment.
ikona uses neurobiology and storytelling to make personalized learning possible, and visible, at scale. The company uses an online platform, immersive education, personal learning pathways and access to a team of expert educators to bring health literacy, clarity and confidence to millions, starting with those affected by kidney disease.
Liver disease is one of the fastest growing causes of morbidity and mortality around the world with over 2B people globally living with or at risk of liver disease. Oncoustics creates advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need, beginning with liver disease. Oncoustics applies AI to raw ultrasound signals to rapidly differentiate healthy versus diseased. There’s a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Our patented approach can be used on any anatomical region that ultrasound can image making this a dynamic and expandable platform that will revolutionize diagnostics. Our goal is to provide early, point of care, non-invasive diagnosis, avoid unnecessary biopsy and help patients, clinicians and payers address a growing healthcare crisis.
Realyze Intelligence uses artificial intelligence and natural language processing to identify precise patient populations with chronic diseases and cancer to ensure they receive the most beneficial treatments. The Realyze clinical intelligence platform “reads” both the detailed clinical notes and structured data from patients’ electronic medical records (EMR). This deeper knowledge can be used by clinicians to identify precisely defined cohorts of patients who may be at higher risk of poor health outcomes, and those individuals can then be prioritized to receive appropriate care in a timely fashion.
Sage Health builds software automation tools to simplify insurance and benefits navigation for the uninsured. This drives revenue to providers and payers and also helps correct health inequities.
